Us Congress 2025-2026 Regular Session

Us Congress House Bill HB4395

Introduced
7/15/25  

Caption

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

Impact

The bill mandates the establishment of research databases for tracking the prevalence and treatment of uterine fibroids under Medicaid and the Children's Health Insurance Services (CHIP). It emphasizes the need for public education surrounding fibroids, including treatment options that are often overlooked. By allocating an estimated $30 million annually from 2026 to 2030 towards these efforts, the bill aims to improve federal and state healthcare outcomes, thereby positively influencing healthcare access and standards for fibroid patients across the nation. A report is also required to be submitted to Congress regarding expenditures on these healthcare services.

Summary

House Bill 4395, known as the 'Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025,' aims to enhance research, education, and treatment options for individuals suffering from uterine fibroids. This legislation acknowledges the significant impact uterine fibroids have on women's health, particularly for those in minority populations, and seeks to address the gaps in understanding and treatment availability. Approximately 20% to 50% of women in reproductive age are estimated to have fibroids, with severe symptoms affecting countless individuals, highlighting the urgency for dedicated research and resources.

Contention

One of the notable points of contention surrounding HB4395 is the long-standing underfunding of uterine fibroid research, particularly when compared to the overall burden of the disease. In 2019, for instance, NIH funding for fibroid research was notably low, raising concerns among advocates about equity in health research funding. Moreover, the bill addresses the disparity in healthcare access and treatment experiences between racial groups, particularly emphasizing how Black individuals experience greater hospitalization rates and more severe symptomatology associated with fibroids. Critics of the lack of awareness and research may see the proposed measures as a necessary move towards health equity.

Companion Bills

US SB2275

Related Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

Previously Filed As

US HB4572

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023

US SB2303

Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023

US HR1580

Supporting the designation of July as Uterine Fibroids Awareness Month.

US HB8247

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024

US HB9782

Uterine Cancer Study Act of 2024

US HB10439

To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.

US HB9907

Long COVID Research Moonshot Act

US HB8601

Liver Illness Visibility, Education, and Research Act of 2024

US HB10297

Thyroid Disease CARE Act of 2024 Thyroid Disease Coverage, Awareness, Research, and Education Act of 2024

US HB4273

LGBTQI+ and Women’s History Education Act of 2023

Similar Bills

CA SB536

Firearm Violence Research Center: gun violence restraining orders.

CA AB922

Reproductive health and research: oocyte procurement.

CA AB818

Protective orders.

CA SB442

State parks: resource exploitation exceptions: commercialization of investigation results.

CA SB706

Public health: pulmonary hypertension task force.

CA AB829

Richard Paul Hemann Parkinson’s Disease Program: Parkinson’s Disease Research Voluntary Tax Contribution Fund.

CA SB391

Community colleges: Chancellor of the California Community Colleges: data request fee policy.

CA SB440

Personal income taxes: voluntary contributions: California Breast Cancer Research Voluntary Tax Contribution Fund and California Cancer Research Voluntary Tax Contribution Fund.